Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544294PMC
http://dx.doi.org/10.1097/HS9.0000000000000488DOI Listing

Publication Analysis

Top Keywords

fair pricing
4
pricing innovative
4
innovative medicines
4
medicines eha
4
eha position
4
position paper
4
fair
1
innovative
1
medicines
1
eha
1

Similar Publications

Research typically promotes two types of outcomes (inventions and discoveries), which induce a virtuous cycle: something suspected or desired (not previously demonstrated) may become known or feasible once a new tool or procedure is invented and, later, the use of this invention may discover new knowledge. Research also promotes the opposite sequence-from new knowledge to new inventions. This bidirectional process is observed in geo-referenced epidemiology-a field that relates to but may also differ from spatial epidemiology.

View Article and Find Full Text PDF

Objective: Due to the poor skin mobility of the heel, there are few reports on the efficacy and safety of skin-stretching devices in the treatment of soft-tissue defects of the heel. Redesigning the claws of the stretching devices may be one of the solutions to the problem. This study was designed to investigate the clinical effect of self-modified skin-stretching device in the treatment of soft-tissue defects in the heel.

View Article and Find Full Text PDF

Purpose: This study aims to develop and implement an economic evaluation using a micro-costing approach to provide a precise and transparent analysis of the direct costs of cystoscopic procedures in Korean hospitals. The study seeks to identify key cost components and evaluate whether current reimbursement rates accurately reflect these direct costs.

Materials And Methods: Significant variations in cost items were identified across different studies.

View Article and Find Full Text PDF

Revising EU pharmaceutical legislation: will it foster drug repurposing?

Drug Discov Today

January 2025

Department of Clinical Epidemiology & Medical Technology Assessment (KEMTA), Maastricht University Medical Centre, Maastricht, the Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, the Netherlands; REPO4EU consortium.

Repurposing off-patent drugs can be a potential source of low-cost treatments for patients with unmet medical needs. Here, we review the proposed new European Union (EU) pharmaceutical legislation in which two articles address drug repurposing. We find certain barriers hindering the adoption of these new incentives by academic and not-for-profit stakeholders, including lack of knowledge on regulatory aspects, pharmacovigilance, and restrictions in data protection.

View Article and Find Full Text PDF

Payment Matters: Understanding Payer Perspectives on Laboratory Stewardship.

J Appl Lab Med

January 2025

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, United States.

Background: The US healthcare system is complex and includes a number of entities and systems that provide services to patients and to pay for them. While improving health and well-being are accepted goals of healthcare, the 3 stakeholder groups relevant to healthcare-patients, providers, and payers-often have different perspectives on how care should be utilized, performed, and paid for. These differing perspectives are discussed as they relate to clinical laboratory testing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!